- POSITIVE
Annual Revenue Anondita Medicare Mar-2026 Annual Revenue is Rs 113 Cr which is growth of 86.4% YoY.
- POSITIVE
Annual Net Profit Anondita Medicare Mar-2026 Annual Net Profit is Rs 27 Cr which is growth of 148.3% YoY.
Anondita Medicare was incorporated on March 12, 2024. The company manufactures flavored male condoms under the brand “COBRA,” which are 100% electronically tested and packed in export-quality material, and has also started producing female condoms. With an annual capacity of ~562 million pieces, it follows sustainable practices by using CNG as an eco-friendly fuel in its plant
| Bidding Dates |
|---|
| 22 Aug 2025 - 26 Aug 2025 |
| Subscription |
|---|
| 277.48x Oversubscribed |
| Minimum Investment | Minimum Lot | Maximum Lot | Lot Size | Number of Shares | Issue Price Band | Post Issue Promoter Holding % | Issue Size | IPO Document |
|---|---|---|---|---|---|---|---|---|
| ₹274,000 | 2 | 2 | 1000 | 4.8 M | ₹137 - ₹145 | 61.71 % | ₹656.6 M - ₹695.0 M | RHP DOC |
Anondita Medicare IPO SUBSCRIPTION STATUS
26 Aug '25Total277.48x
Retail Individual Investor376.95x
HNI (NII) Investors701.84x
Qualified Institutional Buyers80.54x
Anondita Medicare IPO overall subscription rate was 277.48 times the total available shares
Anondita Medicare IPO retail subscription rate was 376.95 times in the retail segment
Anondita Medicare IPO non-institutional investor subscription rate was 701.84 times in the non-institutional investor category
Anondita Medicare IPO Qualified Institutional Bidder subscription rate was 80.54 times the available shares for Qualified Institutional Bidder
| Day | Retail Individual Investor | HNI (NII) Investors | Qualified Institutional Buyers |
|---|---|---|---|
| Category Reservation | 35% | 15% | 50% |
26 Aug 2025 (Day 3) | 376.95x | 701.84x | 80.54x |
25 Aug 2025 (Day 2) | 72.76x | 75.14x | 1.14x |
22 Aug 2025 (Day 1) | 7.62x | 2.53x | 0.06x |
Anondita Medicare FINANCIALS
| Period | Revenue from Operations (Rs in crore) | Net Profit (Rs in crore) | Cash Flow from Operations (Rs in crore) | Free Cash Flow (Rs in crore) | Margins |
| FY25 | 77.0 | 16.4 | -10.5 | -17.4 | 33.3% |
| FY24 | 46.4 | 3.8 | 10.5 | 6.5 | 19.6% |
| FY23 | 35.9 | 0.3 | -9.5 | -9.8 | 10.0% |
Anondita Medicare IPO SUBSCRIPTION STATUS DETAILS
Anondita Medicare had 4.8 M shares on offer
Anondita Medicare IPO offer price was in the range ₹137 - ₹145
Anondita Medicare IPO minimum Investment was ₹274000
Anondita Medicare IPO issue size was ₹ 656.6 M - ₹ 695.0 M
Anondita Medicare had a minimum lot size of 1000 Shares per application
Anondita Medicare NUMBER OF SHARES ON OFFER
Total4.8 M
Fresh Issue4.8 M
Offer for Sale0
Post Issue Promoter Holding %61.71 %
Anondita Medicare IPO IMPORTANT DATES
| Issue Open Date | 22 Aug 2025 |
| Issue close Date | 26 Aug 2025 |
| Allotment Date | 28 Aug 2025 |
| Refund Date | 29 Aug 2025 |
| Demat Account Credit Date | 29 Aug 2025 |
| Listing Date | 01 Sep 2025 |
| Listing on Exchange(s) | NSE |
| Anondita Medicare Allotment Status | Exchange/ Registrar |
Anondita Medicare IPO subscription opened on 22 Aug 2025, and closed on 26 Aug 2025
IPO allotment for Anondita Medicare was finalized on Thursday, 28 Aug 2025
IPO listing for Anondita Medicare was on NSE on Monday, 01 Sep 2025
Anondita Medicare IPO LISTING GAINS
| Issue Price (adjusted) | 145.0 |
| Listing Open Price | 275.5 |
| Listing Close Price | 289.3 |
| Listing Gain% | 90.0% |
| Current Gain% | 638.5% |
Anondita Medicare Peer
| Stock | Stock Price | Market Cap (Rs crore) | PE TTM | PEG TTM | PS TTM | ROE% | ROA% | Annual Revenue (Rs crore) | Annual Revenue Growth % | Annual Net Profit (Rs crore) | Annual Net Profit Growth % | EPS TTM | EPS TTM Growth % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anondita Medicare Ltd. | 1070.8 | 1936.7 | 61 | 0.6 | 14 | 25.9 | 18.1 | 138.3 | 79.3 | 33.4 | 111.8 | 17.6 | 101.1 |
| Hindustan Unilever Ltd. | 1865.4 | 438292.8 | 29.3 | 0.8 | 6.6 | 30.8 | 18.8 | 65219 | 1.7 | 15040 | 41.2 | 63.7 | 38.6 |
| Marico Ltd. | 787.2 | 102358.6 | 54.2 | 4.1 | 7.2 | 41.8 | 17.5 | 13815 | 25.1 | 1762 | 8.2 | 14.5 | 13.1 |
| Godrej Consumer Products Ltd. | 865.6 | 88585.8 | 46.3 | 14.4 | 5.5 | 14.7 | 8.7 | 15444.1 | 5.2 | 1861.5 | 0.5 | 18.7 | 3.2 |
| Dabur India Ltd. | 383.6 | 68040.1 | 34.5 | 3.2 | 5 | 16.6 | 10.8 | 13792.3 | 5.2 | 1895 | 7.2 | 11.1 | 10.7 |
| Colgate-Palmolive (India) Ltd. | 1757.4 | 47798.7 | 35.5 | -10.8 | 7.7 | 83.7 | 38.9 | 6124.2 | -0.9 | 1325.3 | -7.8 | 49.6 | -3.3 |
Annual
Balance Sheet
Ratios
Cash Flow
Anondita Medicare annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
| Indicator | Graph | CAGR 3 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 |
|---|---|---|---|---|---|---|
46.5% | 113.5 | 60.9 | 36.1 | |||
Operating Exp. Ann. | 30.9% | 72.4 | 42.6 | 32.3 | ||
Operating Profit Ann. | 121.8% | 39.3 | 17.9 | 3.6 | ||
OPM Ann. % | 51.8% | 34.65% | 29.38% | - | 9.90% | |
29.1% | 76.9 | 46.4 | 35.7 | |||
EBITDA Ann. | 121.1% | 41.1 | 18.3 | 3.8 | ||
EBITDA Ann. margin % | 51% | 36.20% | 29.97% | - | 10.52% | |
Interest Ann. | 9% | 3.5 | 2.9 | 2.7 | ||
Depr. | 22.4% | 1.1 | 0.9 | 0.6 | ||
PBT Ann. | 317.9% | 36.5 | 14.4 | 0.5 | ||
Tax Ann. | 359.5% | 9.7 | 3.6 | 0.1 | ||
306.2% | 26.8 | 10.8 | 0.4 | |||
Net Profit Ann. | 306.2% | 26.8 | 10.8 | 0.4 | ||
NPM Ann. % | 192.4% | 24.01% | 17.84% | 0.96% | ||
EPS Adj. latest Ann. | 313.1% | 14.1 | 5.7 | 0.2 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
86.4%
3Y CAGR
46.5%
Net Profit Ann.
1Y CHG
148.1%
3Y CAGR
306.2%
Operating Exp. Ann.
1Y CHG
70%
3Y CAGR
30.9%
Anondita Medicare INFORMATION ON IPO ISSUE
About Anondita Medicare
Anondita Medicare was incorporated on March 12, 2024. The company manufactures flavored male condoms under the brand “COBRA,” which are 100% electronically tested and packed in export-quality material, and has also started producing female condoms. With an annual capacity of ~562 million pieces, it follows sustainable practices by using CNG as an eco-friendly fuel in its plant
Object of the Issue
- Funding capital expenditure requirements for the purchase of equipment/machineries
- Funding the working capital requirements of the company
- To meet out the expenses for unidentified acquisition and general corporate purposes
Anondita Medicare - PROMOTERS
| Name |
|---|
| Anupam Ghosh |
| Sonia Ghosh |
| Reshant Ghosh |
Anondita Medicare - MANAGEMENT & LEADERSHIP
| Name | Designation |
|---|---|
| Anupam Ghosh | Managing Director |
| Sonia Ghosh | Whole-Time Director |
| Reshant Ghosh | Whole-Time Director |
| Lakhinder Singh | Non-Independent Director |
| Nishi Goel | Independent Director |
| Gaurav Kumar | Independent Director |
Anondita Medicare Book Running Lead Manager
Narnolia Financial Services Limited
ipo@narnolia.com
Anondita Medicare Registrar to the issue
Maashitla Securities Private Limited
ipo@maashitla.com
Anondita Medicare Strengths
Quality control
Quality control checks are conducted at key stages, including latex compounding, dipping for thickness and strength, post-treatment (washing, drying, cooling), lubricant/flavor preparation, and foiling and packing to ensure hygiene and durability
Strength
Sales channel
The company distributes products through M/s Calcutta Cosmetics and its subsidiary, M/s Anondita Healthcare & Rubber Products Limited, which markets the “COBRA” brand. Its sales team engages with channel partners, government procurement agencies, and AIDS Control Societies, with past exports also undertaken
Strength
Skilled manpower
The company’s workforce combines experience with youth, providing both stability and growth. Skilled resources, efficient processes, and strong management have supported the successful execution of its growth plans
Strength
Anondita Medicare Risks
Depend on govt contracts
The company earns a major share of its revenue from government contracts and tenders for supplying condoms under public health programs. Failure to meet tender requirements could lead to disqualification from future tenders, adversely impacting its business, financial condition, and operations
Risk
Quality standards
Pharmaceutical companies like this one must comply with regulations and quality standards set by agencies such as CDSCO, The Rubber Board, and the Ministry of Commerce & Industry. Their facilities are subject to periodic inspections, and products may face recalls or voluntary withdrawals due to quality issues or regulatory changes
Risk
Capital intensive
The company requires substantial working capital for daily operations and business growth. Any delay or inability to secure sufficient working capital on favourable terms could adversely affect its operations, profitability, and growth prospects
Risk
IPO FAQs
The promoters of the company are Anupam Ghosh, Sonia Ghosh and Reshant Ghosh.
The category allocation of qualified institutional buyers is 50.0%, the category allocation of non individual investors or high networth individuals is 15.0% and for retail investors it is 35.0%.
The price band of the IPO is Rs 137.0 - 145.0.
The IPO application opens on Aug 22, 2025 and closes on Aug 26, 2025.
The minimum lot size for the IPO is 2000. The maximum lot size for the IPO is 2000.
For all category investors, the minimum application amount for this IPO is Rs. 274,000.0, the maximum value for this IPO is Rs 290,000.0.
This IPO will be allotted on Aug 28, 2025.
The refund will be credited to your account on Aug 29, 2025.
The allotted shares will be credited to your demat on Aug 29, 2025.
Anondita Medicare Ltd.’s shares listed on the stock exchanges on Sep 01, 2025.